Mr. Chair, I was happy to hear the words of the member for Glengarry--Prescott--Russell. I must confess that I have not yet had a chance to read his book; I am waiting for the movie and for volume two of his book.
There is a question that I would like to ask. I have listened to the debate and to where people are on that question of balancing economic interests and legitimate business with protection for Canadians. Let us look at the strategy that the minister has put forward. First, we would have a surveillance system of the drug network. This network would indicate exactly what the supply is in Canada and would monitor it. I think everybody would agree that this is a good move.
On the second point, I note that the member is an experienced member of Parliament who has done a lot of work internationally respecting Canada's role in the world and our need for trade and respecting our trade agreements. Under the strategy the minister has put forward, we know that if there is a human safety reason for restricting drug shipments, we can. The network would give us that information and we would have the tools to do that after the legislation is passed.
The true point remains, this last point that is contentious, and it is the question of the ethics of practice. Where we have those principles in Canada, at the Colleges of Pharmacists and those professional organizations, a pharmacist will only fill a prescription that has been written by a doctor licensed to practice in Canada. There is the question of having a relationship. That question remains for some interesting debate on how we balance that with the current operations of Internet pharmacies.
Would the member comment on those points?